Industries

US manufacturer Bolb annouces its UVC LED S3535-H. This emitter, which is distributed by LASER COMPONENTS, generates an output power of more than 150mW per chip and provides the strongest germicidal effect currently available on the market.

The world’s first electric hydrofoil ferry has begun its service. Candela P-12 "Nova" sets out to eliminate emissions from Stockholm’s public transport while halving commute times.

Advantest will feature its latest test solutions for advanced ICs at the 2024 International Test Conference (ITC) at the Hilton San Diego Bayfront (November 3-8).

Keysight Technologies and Analog Devices (ADI), a global semiconductor specialist, have collaborated to create a comprehensive test solution for Gigabit Multimedia Serial Link (GMSL2TM) devices.

Toshiba Electronics has partnered with MIKROE to integrate its Smart Motor Control Driver IC (SmartMCD) into the SmartMCD TB9M003FG board, streamlining prototyping phase for automotive applications.

Improved diagnosis and treatment for eye diseases affecting the sight of millions across the globe has taken a major step forward, after Bristol-based health technology startup Siloton became the first commercial organisation in the world to take a sub-surface image of a human retina using photonic chip technology.

The AM68 scalable processor family is based on the evolutionary Jacinto 7 architecture, targeted at Smart Vision Camera and General Compute applications and built on extensive market knowledge accumulated over a decade of TI’s leadership in the Vision processor market.

The Faraday Institution’s latest report on UK gigafactories finds that they could support 35,000 jobs by 2040, along with a further 65,000 in the supply chain, but warns that the UK is not moving quickly enough.

DENSO and US startup Quadric have signed a development license agreement for a Neural Processing Unit (NPU), which is a semiconductor specialised for the arithmetic processing of AI.

Researchers from Texas A&M University are working on developing 3D-printed medication for treating the parasitic infection toxoplasmosis in children. Their aim is to make the treatment more accurate, accessible, and cost-effective as well as improving safety, compared to current options.